Stock Comparison

TALK vs UNH

Talkspace Inc vs UnitedHealth Group Inc

Who's the better investment? Let's break it down.

The Verdict

TALK takes this one.

This one's close — only 0.2 points separating them. TALK wins by a hair, but both deserve a closer look.

Winner

TALK

Talkspace Inc

0.5

out of 10

Distressed

UNH

UnitedHealth Group Inc

0.3

out of 10

Distressed

Want to compare any two stocks?

Valuation

TALK

Metric

UNH

$851M

Market Cap

$365.5B

102.8

P/E Ratio

Lower may indicate better value

30.3

0.0

Forward P/E

18.2

0.0

Price/Book

6.4

0.0

EV/EBITDA

16.8

Profitability & Growth

TALK

Metric

UNH

3.4%

Profit Margin

2.7%

60.0%

Gross Margin

18.5%

0.0%

Operating Margin

4.1%

7.0%

Return on Equity

12.4%

0.0%

Return on Assets

3.9%

22.0%

Revenue Growth

9.7%

$0.05

EPS

$13.24

Financial Health

TALK

Metric

UNH

0.0

Debt-to-Equity

Lower = less leverage

0.8

0.0

Current Ratio

Above 1.0 is healthy

0.9

1.2

Beta

Lower = less volatile

0.6

None

Dividend Yield

2.3%

Risk Comparison

TALK

Overall

Moderate

Financial

Low

Market

Low

Competitive

Low

Execution

Low

Regulatory

Medium

What Could Go Wrong

The acquisition by Universal Health Services for $5.25 per share could fail to close if regulatory approvals are not granted or if shareholder opposition (like the Ademi Firm's investigation) leads to...

Red Flags

🚩Acquisition caps all public equity upside to $5.25/share.
🚩Shareholder investigation by Ademi Firm into fair price and insider benefits.

UNH

Overall

Moderate

Financial

Low

Market

Medium

Competitive

Low

Execution

Low

Regulatory

High

What Could Go Wrong

The ongoing DOJ criminal and civil investigation, if it leads to significant penalties, forced divestitures, or operational restrictions, could severely impact Optum's growth trajectory and UNH's over...

Red Flags

🚩DOJ criminal and civil investigation: Presents an unquantified but potentially significant regulator...
🚩Reported membership contracting by 1.3 million in 2026 (from secondary source): If verified in futur...
🚩Very low insider ownership (0.28%): While common for mega-caps, it suggests less direct alignment wi...

Competitive Moat

TALK

Rating

🛡️ Narrow

Trend

📈 Expanding

Brand PowerSwitching Costs (for enterprise clients/payers)Network Effects (provider-patient matching)

UNH

Rating

🛡️ Wide

Trend

➡️ Stable to Expanding

Efficient ScaleSwitching CostsIntangible Assets/IP (data, analytics, proprietary care models)Brand Power

Investment Thesis

TALK0.5/10

The investment thesis for Talkspace has shifted from a high-growth, turnaround play to a pure arbitrage opportunity. The company, having successfully pivoted to B2B and achieved adjusted EBITDA profitability, attracted an acquisition offer from UHS at $5.25/share. For current public shareholders, the focus is now on the successful closing of this cash acquisition, not on future independent growth ...

Full TALK Analysis

UNH0.3/10

If Optum continues to expand its health services and technology footprint at high-single-digit to low-double-digit rates, while UnitedHealthcare maintains stable profitability and manages its medical loss ratio, then UNH will deliver consistent EPS growth (high-single digits) and dividend increases. This makes UNH a reliable compounder for long-term capital appreciation and income, not a high-grow...

Full UNH Analysis

Price Targets & Strategy

Price Targets & Entry/Exit Strategy

Growth Catalysts

Growth Catalysts Comparison

Market Sentiment

Market Sentiment Analysis

The Deep Dive

TALK0.5/10

The definitive agreement for Universal Health Services (UHS) to acquire Talkspace (TALK) for $5.25 per share fundamentally alters its investment profile. While the company demonstrated strong Q4 2025 earnings, positive adjusted EBITDA, and a robust balance sheet, the stock's upside is now capped at the acquisition price, effectively eliminating any potential for a 10x return as an independent public entity. The previous score reflected the company's significant turnaround and growth potential; h...

Full TALK Analysis

UNH0.3/10

UnitedHealth Group (UNH) remains a robust, high-quality mega-cap in the mature and highly regulated healthcare sector. Q1 2026 adjusted EPS of $7.23, a recent dividend increase to $2.32, and some analyst upgrades (e.g., Truist to $440, Goldman Sachs Conviction Buy) reflect solid operational performance and financial strength. However, these are characteristics of a stable compounder, not a company capable of 10x growth within 3-5 years. Its immense scale, market maturity, and regulatory landscap...

Full UNH Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Analyze Any Stock →View Top 100 →

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified financial advisor before making investment decisions.